慢性淋巴细胞白血病患者的急性髓系白血病:(临床病例)诊断挑战
- 作者: Fernandes M.1, Martins J.1, Campos M.2, Magalhães C.2, Eremina Y.3,4
-
隶属关系:
- Hospital Pedro Hispano, Unidade Local de Saúde de Matosinhos,EPE
- Hospital Pedro Hispano, Unidade Local de Saúde de Matosinhos, EPE
- Hospital Pedro Hispano, Unidade Local de Saúde de Matosinhos, EPE, Matosinhos
- Institute of Public Health of the University of Porto
- 期: 卷 29, 编号 1 (2021)
- 页面: 130-133
- 栏目: Clinical reports
- URL: https://journals.rcsi.science/pavlovj/article/view/61145
- DOI: https://doi.org/10.23888/PAVLOVJ2021291130-133
- ID: 61145
如何引用文章
详细
很少有报告涉及慢性淋巴细胞白血病(CLL)和急性髓细胞白血病(AML)在同一患者中共存的情况,而这种现象经常是由化疗药物导致的。癌症患者的血液参数变化可能被解释为疾病进展或与积极治疗相关的医源性影响,从而导致诊断延迟。在本文中,我们呼吁大家留意AML在CLL患者中的进展及对其诊断的挑战。
作者简介
Marta Sofia Fernandes
Hospital Pedro Hispano, Unidade Local de Saúde de Matosinhos,EPE
编辑信件的主要联系方式.
Email: martascf23@gmail.com
ORCID iD: 0000-0003-1900-1639
MD, Resident in Clinical Pathology
葡萄牙, Matosinhos, PortugalJoana Martins
Hospital Pedro Hispano, Unidade Local de Saúde de Matosinhos,EPE
Email: JoanaMaria.Martins@ulsm.min-saude.pt
MD, Specialist in Clinical Hematology, Department of Clinical Hematology
葡萄牙, Matosinhos, PortugalMaria Antónia Campos
Hospital Pedro Hispano, Unidade Local de Saúde de Matosinhos, EPE
Email: antonia.campos@ulsm.min-saude.pt
ORCID iD: 0000-0001-8016-8660
MD, Consultant in Clinical Pathology, Department of Clinical Pathology
葡萄牙, Matosinhos, PortugalCacilda Magalhães
Hospital Pedro Hispano, Unidade Local de Saúde de Matosinhos, EPE
Email: cacilda.magalhaes@ulsm.min-saude.pt
ORCID iD: 0000-0001-7407-4908
MD, Consultant in Clinical Pathology, Director of the Department of Clinical Pathology
葡萄牙, Matosinhos, PortugalYuliana Eremina
Hospital Pedro Hispano, Unidade Local de Saúde de Matosinhos, EPE, Matosinhos; Institute of Public Health of the University of Porto
Email: yuliana.eremina@ulsm.min-saude.pt
ORCID iD: 0000-0002-3656-7266
Researcher ID: ABD-8614-2020
MD, PhD, Specialist in Clinical Pathology, Assistant of the Department of Clinical Pathology, Hospital Pedro Hispano, Unidade Local de Saúde de Matosinhos, EPE, Matosinhos; Collaborator of Environmental and Laboratorial Epidemiology Research Group (EPIUnit), Environmental Health Department
葡萄牙, Matosinhos, Portugal参考
- Giri S, Bhatt VR, Khanal S, et al. Treatment-related acute myeloid leukemia in a chronic lymphocytic leukemia patient: role of fludarabine? Therapeutic Advances in Hematology. 2015;6(2):88-92. doi:10. 1177/2040620714566567
- Al Mussaed E, Osman H, Elyamany G. Simultaneous existence of acute myeloid leukemia and chronic lymphocytic leukemia: a case report. BMC Cancer. 2016;16(1):739. doi: 10.1186/s12885-016-2780-5
- Dong Q, Xiu Y, Bossler A, et al. CLL dedifferentiation to clonally related myeloid cells. Blood Advances. 2020;4(24):6169-74. doi: 10.1182/blood advances.2020002726
- Schoorl M, Schoorl M, Chevallier M, et al. Flagging performance of the Sysmex XN2000 haematology analyser. International Journal of Laboratory Hematology. 2016;38(2):160-6. doi:10.1111/ ijlh.12461
- Furundarena JR, Sainz M, Uranga A, et al. Comparison of abnormal cell flagging of the hematology analyzers Sysmex XN and Sysmex XE-5000 in oncohematologic patients. International Journal of Laboratory Hematology. 2017;39(1):58-67. doi:10. 1111/ijlh.12575
- Eilertsen H, Saether PC, Henriksson CE, et al. Evaluation of the detection of blasts by Sysmex hematology instruments, CellaVision DM96, and manual microscopy using flow cytometry as the confirmatory method. International Journal of Laboratory Hematology. 2019;41(3):338-44. doi: 10.1111/ijlh.12980